ReviewDrug design, development and therapy2012

Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.

Lindsay S Keir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.